1. Home
  2. RDIB vs LXRX Comparison

RDIB vs LXRX Comparison

Compare RDIB & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDIB
  • LXRX
  • Stock Information
  • Founded
  • RDIB 1937
  • LXRX 1995
  • Country
  • RDIB United States
  • LXRX United States
  • Employees
  • RDIB N/A
  • LXRX N/A
  • Industry
  • RDIB Movies/Entertainment
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDIB Consumer Discretionary
  • LXRX Health Care
  • Exchange
  • RDIB Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • RDIB 140.2M
  • LXRX 124.4M
  • IPO Year
  • RDIB N/A
  • LXRX 2000
  • Fundamental
  • Price
  • RDIB $10.00
  • LXRX $0.67
  • Analyst Decision
  • RDIB
  • LXRX Buy
  • Analyst Count
  • RDIB 0
  • LXRX 4
  • Target Price
  • RDIB N/A
  • LXRX $3.67
  • AVG Volume (30 Days)
  • RDIB 3.5K
  • LXRX 32.9M
  • Earning Date
  • RDIB 05-14-2025
  • LXRX 05-05-2025
  • Dividend Yield
  • RDIB N/A
  • LXRX N/A
  • EPS Growth
  • RDIB N/A
  • LXRX N/A
  • EPS
  • RDIB N/A
  • LXRX N/A
  • Revenue
  • RDIB $210,527,000.00
  • LXRX $31,081,000.00
  • Revenue This Year
  • RDIB $11.97
  • LXRX N/A
  • Revenue Next Year
  • RDIB $6.40
  • LXRX $63.36
  • P/E Ratio
  • RDIB N/A
  • LXRX N/A
  • Revenue Growth
  • RDIB N/A
  • LXRX 2481.48
  • 52 Week Low
  • RDIB $5.78
  • LXRX $0.28
  • 52 Week High
  • RDIB $21.34
  • LXRX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • RDIB 69.57
  • LXRX 66.86
  • Support Level
  • RDIB $9.01
  • LXRX $0.49
  • Resistance Level
  • RDIB $10.00
  • LXRX $0.60
  • Average True Range (ATR)
  • RDIB 0.72
  • LXRX 0.07
  • MACD
  • RDIB 0.28
  • LXRX 0.02
  • Stochastic Oscillator
  • RDIB 100.00
  • LXRX 94.30

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Share on Social Networks: